Opendata, web and dolomites

Bacticon1

BACTerial detection and CONtrol of urinary tract infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Bacticon1 project word cloud

Explore the words cloud of the Bacticon1 project. It provides you a very rough idea of what is the project "Bacticon1" about.

biomodics    pursuing    incur    suited    portfolio    fact    approval    commercialised    asia    monitoring    technological    sales    markets    nanoparticles    biomarkers    547    die    temperature    market    solution    catheter    urinary    med    place    benchmarking    prolonged    sustainability    delay    615    fourth    bacticon    50    revenue    measuring    add    dominating    false    death    patients    western    innovation    possibilities    prototype    company    biomarker    precise    blood    severe    stays    conducting    world    problem    care    economical    days    efficient    things    caused    catheters    nano    business    feasibility    time    channels    acquired    patient    marketing    expenses    route    urological    faster    hybrid    positives    hospital    verify    economic    socio    approx    stream    search    tech    american    biosensor    remaining    strategy    infections    mean    infection    indicates    model    bio    option    material    rates    excessive    detection    adjust    impregnation   

Project "Bacticon1" data sheet

The following table provides information about the project.

Coordinator
BIOMODICS APS 

Organization address
address: STENGARDS ALLE 31 A
city: KGS LYNGBY
postcode: 2800
website: www.biomodics.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website http://www.biomodics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMODICS APS DK (KGS LYNGBY) coordinator 50˙000.00

Map

 Project objective

Problem Approx. 50% of all patients with severe blood stream infections die from the infections, while the remaining 50% incur excessive socio-economic expenses from prolonged hospital stays. In fact, the fourth largest cause of death in the western world is hospital and care acquired infections, most often caused by urinary catheters. Present state-of-the-art, measuring the temperature of a patient, indicates if the patient has an infection, but with approx. 2-3 days delay, and with many possibilities for false positives (increasing temperature can mean other things than infection).

Solution The innovation, the Bacticon Catheter, is a catheter impregnation technology based on a new biosensor/biomarker principle based on biomarkers, bio-nanoparticles and nano-channels in a new hybrid material, allowing for an immediate detection. The system is an add-on to existing catheters and is therefore cost efficient and face a faster route through approval procedures, providing much more precise and real-time monitoring.

Project The project has three objectives: 1: Technological feasibility study: Verify and adjust an integrated prototype 2: User feasibility study: Verify the product need by conducting a market and user study, a product innovation strategy, partner search, feasibility of concept, benchmarking with other products and a go-to-market strategy. 3: Economical feasibility study: Analyse the economical sustainability of the product

Business model The innovation is well suited to be commercialised through the sales and marketing channels of a med-tech company, which is already established in the market place, and where the Bacticon Catheter can be integrated in the existing product portfolio of such med-tech company. BioModics is pursuing this option as priority one.

Market The dominating markets are the American market with a 547 M€ urological catheter revenue and Europe with 615 M€. Increasing growth rates are expected, especially in Asia, Europe and US.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTICON1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BACTICON1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More